Clinical significance of sCD163 and its possible role in asthma (Review)
- Authors:
- Yue Zhi
- Peng Gao
- Xiuqin Xin
- Wei Li
- Lei Ji
- Lin Zhang
- Xueyang Zhang
- Jie Zhang
-
Affiliations: Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Jilin University, Changchun, Jilin 130022, P.R. China - Published online on: March 24, 2017 https://doi.org/10.3892/mmr.2017.6393
- Pages: 2931-2939
-
Copyright: © Zhi et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
 |
|
Becker M, De Bastiani MA, Parisi MM, Guma FT, Markoski MM, Castro MA, Kaplan MH, Barbé-Tuana FM and Klamt F: Integrated transcriptomics establish macrophage polarization signatures and have potential applications for clinical health and disease. Sci Rep. 5:133512015. View Article : Google Scholar : PubMed/NCBI | |
|
Vishwanath P, Prashant A, Nataraj SM, Kotekar N and Doddamani P: Can soluble CD163 predict outcome of patients with acute respiratory distress from mechanical ventilation? A pilot study. Indian J Crit Care Med. 17:355–358. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Buechler C, Eisinger K and Krautbauer S: Diagnostic and prognostic potential of the macrophage specific receptor CD163 in inflammatory diseases. Inflamm Allergy Drug Targets. 12:391–402. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Bielecki M, Kowal K, Lapinska A, Chyczewski L and Kowal-Bielecka O: Increased release of soluble CD163 by the peripheral blood mononuclear cells is associated with worse prognosis in patients with systemic sclerosis. Adv Med Sci. 58:126–133. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Thomsen HH, Møller HJ, Trolle C, Groth KA, Skakkebæk A, Bojesen A, Høst C and Gravholt CH: The macrophage low-grade inflammation marker sCD163 is modulated by exogenous sex steroids. Endocr Connect. 2:216–224. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Shimizu K, Ogawa F, Yoshizaki A, Akiyama Y, Kuwatsuka Y, Okazaki S, Tomita H, Takenaka M and Sato S: Increased serum levels of soluble CD163 in patients with scleroderma. Clin Rheumatol. 31:1059–1064. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Fabriek BO, Møller HJ, Vloet RP, van Winsen LM, Hanemaaijer R, Teunissen CE, Uitdehaag BM, van den Berg TK and Dijkstra CD: Proteolytic shedding of the macrophage scavenger receptor CD163 in multiple sclerosis. J Neuroimmunol. 187:179–186. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Timmermann M and Högger P: Oxidative stress and 8-iso-prostaglandin F (2alpha) induce ectodomain shedding of CD163 and release of tumor necrosis factor-alpha from human monocytes. Free Radic Biol Med. 39:98–107. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Periyalil HA, Wood LG, Scott HA, Jensen ME and Gibson PG: Macrophage activation, age and sex effects of immunometabolism in obese asthma. Eur Respir J. 45:388–395. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Davis BH and Zarev PV: Human monocyte CD163 expression inversely correlates with soluble CD163 plasma levels. Cytometry B Clin Cytom. 63:16–22. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Etzerodt A, Maniecki MB, Møller K, Møller HJ and Moestrup SK: Tumor necrosis factor α-converting enzyme (TACE/ADAM17) mediates ectodomain shedding of the scavenger receptor CD163. J Leukoc Biol. 88:1201–1205. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Møller HJ, Aerts H, Grønbaek H, Peterslund NA, Petersen Hyltoft P, Hornung N, Rejnmark L, Jabbarpour E and Moestrup SK: Soluble CD163: A marker molecule for monocyte/macrophage activity in disease. Scand J Clin Lab Invest Suppl. 237:29–33. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Verreck FA, de Boer T, Langenberg DM, van der Zanden L and Ottenhoff TH: Phenotypic and functional profiling of human proinflammatory type-1 and anti-inflammatory type-2 macrophages in response to microbial antigens and IFN-gamma- and CD40L-mediated costimulation. J Leukoc Biol. 79:285–293. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Savage ND, de Boer T, Walburg KV, Joosten SA, van Meijgaarden K, Geluk A and Ottenhoff TH: Human anti-inflammatory macrophages induce Foxp3+GITR+CD25+ regulatory T cells, which suppress via membrane-bound TGFbeta-1. J Immunol. 181:2220–2226. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Xu W, Roos A, Schlagwein N, Woltman AM, Daha MR and van Kooten C: IL-10-producing macrophages preferentially clear early apoptotic cells. Blood. 107:4930–4937. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Schmieder A, Schledzewski K, Michel J, Schönhaar K, Morias Y, Bosschaerts T, Van den Bossche J, Dorny P, Sauer A, Sticht C, et al: The CD20 homolog Ms4a8a integrates pro- and anti-inflammatory signals in novel M2-like macrophages and is expressed in parasite infection. Eur J Immunol. 42:2971–2982. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Paulus P, Holfeld J, Urbschat A, Mutlak H, Ockelmann PA, Tacke S, Zacharowski K, Reissig C, Stay D and Scheller B: Prednisolone as preservation additive prevents from ischemia reperfusion injury in a rat model of orthotopic lung transplantation. PLoS One. 8:e732982013. View Article : Google Scholar : PubMed/NCBI | |
|
Duvel A, Frank C, Schnapper A, Schuberth HJ and Sipka A: Classically or alternatively activated bovine monocyte-derived macrophages in vitro do not resemble CD163/Calprotectin biased macrophage populations in the teat. Innate Immun. 18:886–896. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Zizzo G and Cohen PL: IL-17 stimulates differentiation of human anti-inflammatory macrophages and phagocytosis of apoptotic neutrophils in response to IL-10 and glucocorticoids. J Immunol. 190:5237–5246. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Fujimura T, Kambayashi Y, Furudate S, Kakizaki A and Aiba S: A possible mechanism in the recruitment of eosinophils and Th2 cells through CD163(+) M2 macrophages in the lesional skin of eosinophilic cellulitis. Eur J Dermatol. 24:180–185. 2014.PubMed/NCBI | |
|
Onofre G, Koláčková M, Jankovičová K and Krejsek J: Scavenger receptor CD163 and its biological functions. Acta Medica (Hradec Kralove). 52:57–61. 2009. View Article : Google Scholar | |
|
Sulahian TH, Pioli PA, Wardwell K and Guyre PM: Cross-linking of FcgammaR triggers shedding of the hemoglobin-haptoglobin scavenger receptor CD163. J Leukoc Biol. 76:271–277. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Kneidl J, Loffler B, Erat MC, Kalinka J, Peters G, Roth J and Barczyk K: Soluble CD163 promotes recognition, phagocytosis and killing of Staphylococcus aureus via binding of specific fibronectin peptides. Cell Microbiol. 14:914–936. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Knudsen TB, Gustafson P, Kronborg G, Kristiansen TB, Moestrup SK, Nielsen JO, Gomes V, Aaby P, Lisse I, Møller HJ and Eugen-Olsen J: Predictive value of soluble haemoglobin scavenger receptor CD163 serum levels for survival in verified tuberculosis patients. Clin Microbiol Infect. 11:730–735. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Madsen M, Møller HJ, Nielsen MJ, Jacobsen C, Graversen JH, van den Berg T and Moestrup SK: Molecular characterization of the haptoglobin.hemoglobin receptor CD163. Ligand binding properties of the scavenger receptor cysteine-rich domain region. J Biol Chem. 279:51561–51567. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Maniecki MB, Etzerodt A, Moestrup SK, Møller HJ and Graversen JH: Comparative assessment of the recognition of domain-specific CD163 monoclonal antibodies in human monocytes explains wide discrepancy in reported levels of cellular surface CD163 expression. Immunobiology. 216:882–890. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Etzerodt A, Rasmussen MR, Svendsen P, Chalaris A, Schwarz J, Galea I, Møller HJ and Moestrup SK: Structural basis for inflammation-driven shedding of CD163 ectodomain and tumor necrosis factor-α in macrophages. J Biol Chem. 289:778–788. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Subramanian K, Du R, Tan NS, Ho B and Ding JL: CD163 and IgG codefend against cytotoxic hemoglobin via autocrine and paracrine mechanisms. J Immunol. 190:5267–5278. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Møller HJ, Nielsen MJ, Maniecki MB, Madsen M and Moestrup SK: Soluble macrophage-derived CD163: A homogenous ectodomain protein with a dissociable haptoglobin-hemoglobin binding. Immunobiology. 215:406–412. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Craig DG, Lee P, Pryde EA, Hayes PC and Simpson KJ: Serum neopterin and soluble CD163 as markers of macrophage activation in paracetamol (acetaminophen)-induced human acute liver injury. Aliment Pharmacol Ther. 38:1395–1404. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Hintz KA, Rassias AJ, Wardwell K, Moss ML, Morganelli PM, Pioli PA, Givan AL, Wallace PK, Yeager MP and Guyre PM: Endotoxin induces rapid metalloproteinase-mediated shedding followed by up-regulation of the monocyte hemoglobin scavenger receptor CD163. J Leukoc Biol. 72:711–717. 2002.PubMed/NCBI | |
|
Salagianni M, Galani IE, Lundberg AM, Davos CH, Varela A, Gavriil A, Lyytikäinen LP, Lehtimäki T, Sigala F, Folkersen L, et al: Toll-like receptor 7 protects from atherosclerosis by constraining ‘inflammatory’ macrophage activation. Circulation. 126:952–962. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Kowal K, Moniuszko M and Bodzenta-Lukaszyk A: The effect of inhaled corticosteroids on the concentration of soluble CD163 in induced sputum of allergic asthma patients. J Investig Allergol Clin Immunol. 24:49–55. 2014.PubMed/NCBI | |
|
Goldstein JI, Goldstein KA, Wardwell K, Fahrner SL, Goonan KE, Cheney MD, Yeager MP and Guyre PM: Increase in plasma and surface CD163 levels in patients undergoing coronary artery bypass graft surgery. Atherosclerosis. 170:325–332. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Hogger P and Sorg C: Soluble CD163 inhibits phorbol ester-induced lymphocyte proliferation. Biochem Biophys Res Commun. 288:841–843. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Funding M, Vorum H, Nexø E, Moestrup SK, Ehlers N and Møller HJ: Soluble CD163 and interleukin-6 are increased in aqueous humour from patients with endothelial rejection of corneal grafts. Acta Ophthalmol Scand. 83:234–239. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Jude C, Dejica D, Samasca G, Balacescu L and Balacescu O: Soluble CD163 serum levels are elevated and correlated with IL-12 and CXCL10 in patients with long-standing rheumatoid arthritis. Rheumatol Int. 33:1031–1037. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Kneidl J, Mysore V, Geraci J, Tuchscherr L, Löffler B, Holzinger D, Roth J and Barczyk-Kahlert K: Soluble CD163 masks fibronectin-binding protein A-mediated inflammatory activation of Staphylococcus aureus infected monocytes. Cell Microbiol. 16:364–377. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Kusi KA, Gyan BA, Goka BQ, Dodoo D, Obeng-Adjei G, Troye-Blomberg M, Akanmori BD and Adjimani JP: Levels of soluble CD163 and severity of malaria in children in Ghana. Clin Vaccine Immunol. 15:1456–1460. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Andersen ES, Rødgaard-Hansen S, Moessner B, Christensen PB, Møller HJ and Weis N: Macrophage-related serum biomarkers soluble CD163 (sCD163) and soluble mannose receptor (sMR) to differentiate mild liver fibrosis from cirrhosis in patients with chronic hepatitis C: A pilot study. Eur J Clin Microbiol Infect Dis. 33:117–122. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Gaini S, Pedersen SS, Koldkaer OG, Pedersen C, Moestrup SK and Møller HJ: New immunological serum markers in bacteraemia: Anti-inflammatory soluble CD163, but not proinflammatory high mobility group-box 1 protein, is related to prognosis. Clin Exp Immunol. 151:423–431. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Ayarci AO, Yilmaz E, Sigirli D, Budak F, Göral G and Oral HB: Diagnostic value of serum concentrations of high-mobility group-box protein 1 and soluble hemoglobin scavenger receptor in brucellosis. Microbiol Immunol. 57:150–158. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Knudsen TB, Larsen K, Kristiansen TB, Møller HJ, Tvede M, Eugen-Olsen J and Kronborg G: Diagnostic value of soluble CD163 serum levels in patients suspected of meningitis: Comparison with CRP and procalcitonin. Scand J Infect Dis. 39:542–553. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Costa-Hurtado M, Olvera A, Martinez-Moliner V, Galofré-Milà N, Martínez P, Dominguez J and Aragon V: Changes in macrophage phenotype after infection of pigs with Haemophilus parasuis strains with different levels of virulence. Infect Immun. 81:2327–2333. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Carrol ED, Mankhambo LA, Jeffers G, Parker D, Guiver M, Newland P and Banda DL: IPD Study Group, Molyneux EM, Heyderman RS: The diagnostic and prognostic accuracy of five markers of serious bacterial infection in Malawian children with signs of severe infection. PLoS One. 4:e66212009. View Article : Google Scholar : PubMed/NCBI | |
|
Cui Y, Zhang YC, Rong QF and Zhu Y: Changes and significance of soluble CD163 in sepsis and severe sepsis in children. Zhonghua Er Ke Za Zhi. 50:653–656. 2012.(In Chinese). PubMed/NCBI | |
|
Su L, Feng L, Liu C, Jiang Z, Li M, Xiao K, Yan P, Jia Y, Feng D and Xie L: Diagnostic value of urine sCD163 levels for sepsis and relevant acute kidney injury: A prospective study. BMC Nephrol. 13:1232012. View Article : Google Scholar : PubMed/NCBI | |
|
Kjaergaard AG, Rodgaard-Hansen S, Dige A, Krog J, Møller HJ and Tønnesen E: Monocyte expression and soluble levels of the haemoglobin receptor (CD163/sCD163) and the mannose receptor (MR/sMR) in septic and critically ill non-septic ICU patients. PLoS One. 9:e923312014. View Article : Google Scholar : PubMed/NCBI | |
|
Gronbaek H, Sandahl TD, Mortensen C, Vilstrup H, Møller HJ and Møller S: Soluble CD163, a marker of Kupffer cell activation, is related to portal hypertension in patients with liver cirrhosis. Aliment Pharmacol Ther. 36:173–180. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Yang YY, Huang YT, Tsai TH, Hou MC, Lee FY, Lee SD and Lin HC: Kupffer cell depletion attenuates leptin-mediated methoxamine-stimulated portal perfusion pressure and thromboxane A2 release in a rodent model of NASH-cirrhosis. Clin Sci (Lond). 123:669–680. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Bover LC, Cardo-Vila M, Kuniyasu A, Sun J, Rangel R, Takeya M, Aggarwal BB, Arap W and Pasqualini R: A previously unrecognized protein-protein interaction between TWEAK and CD163: Potential biological implications. J Immunol. 178:8183–8194. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Waidmann O, Brunner F, Herrmann E, Zeuzem S, Piiper A and Kronenberger B: Macrophage activation is a prognostic parameter for variceal bleeding and overall survival in patients with liver cirrhosis. J Hepatol. 58:956–961. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Yang YY, Hou MC, Lin MW, Chen PH, Liao WC, Chu CJ and Lin HC: Combined platelet count with sCD163 and genetic variants optimizes esophageal varices prediction in cirrhotic patients. J Gastroenterol Hepatol. 28:112–121. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Kazankov K, Barrera F, Møller HJ, Bibby BM, Vilstrup H, George J and Grønbaek H: Soluble CD163, a macrophage activation marker, is independently associated with fibrosis in patients with chronic viral hepatitis B and C. Hepatology. 60:521–530. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Ye H, Wang LY, Zhao J and Wang K: Increased CD163 expression is associated with acute-on-chronic hepatitis B liver failure. World J Gastroenterol. 19:2818–2825. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Møller HJ, Grønbaek H, Schiødt FV, Holland-Fischer P, Schilsky M, Munoz S, Hassanein T and Lee WM: U.S. Acute Liver Failure Study Group: Soluble CD163 from activated macrophages predicts mortality in acute liver failure. J Hepatol. 47:671–676. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Parkner T, Sorensen LP, Nielsen AR, Fischer CP, Bibby BM, Nielsen S, Pedersen BK and Møller HJ: Soluble CD163: A biomarker linking macrophages and insulin resistance. Diabetologia. 55:1856–1862. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Zanni MV, Burdo TH, Makimura H, Williams KC and Grinspoon SK: Relationship between monocyte/macrophage activation marker soluble CD163 and insulin resistance in obese and normal-weight subjects. Clin Endocrinol (Oxf). 77:385–390. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Diaz-López A, Chacón MR, Bulló M, Maymó-Masip E, Martínez-González MA, Estruch R, Vendrell J, Basora J, Díez-Espino J, Covas MI and Salas-Salvadó J: Serum sTWEAK concentrations and risk of developing type 2 diabetes in a high cardiovascular risk population: A nested case-control study. J Clin Endocrinol Metab. 98:3482–3490. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Møller HJ, Frikke-Schmidt R, Moestrup SK, Nordestgaard BG and Tybjaerg-Hansen A: Serum soluble CD163 predicts risk of type 2 diabetes in the general population. Clin Chem. 57:291–297. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Llauradó G, González-Clemente JM, Maymó-Masip E, Subías D, Vendrell J and Chacón MR: Serum levels of TWEAK and scavenger receptor CD163 in type 1 diabetes mellitus: Relationship with cardiovascular risk factors. A case-control study. PLoS One. 7:e439192012. View Article : Google Scholar : PubMed/NCBI | |
|
Fernandez-Boyanapalli R, Goleva E, Kolakowski C, Min E, Day B, Leung DY, Riches DW, Bratton DL and Sutherland ER: Obesity impairs apoptotic cell clearance in asthma. J Allergy Clin Immunol. 131:1041–1047, 1047.e1-e3. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Shakeri-Manesch S, Zeyda M, Huber J, Ludvik B, Prager G and Stulnig TM: Diminished upregulation of visceral adipose heme oxygenase-1 correlates with waist-to-hip ratio and insulin resistance. Int J Obes (Lond). 33:1257–1264. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Al-Daghri NM, Al-Attas OS, Bindahman LS, Alokail MS, Alkharfy KM, Draz HM, Yakout S, McTernan PG, Sabico S and Chrousos GP: Soluble CD163 is associated with body mass index and blood pressure in hypertensive obese Saudi patients. Eur J Clin Invest. 42:1221–1226. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Kračmerová J, Rossmeislová L, Kováčová Z, Klimčáková E, Polák J, Tencerová M, Mališová L, Štich V, Langin D and Šiklová M: Soluble CD163 is associated with CD163 mRNA expression in adipose tissue and with insulin sensitivity in steady-state condition but not in response to calorie restriction. J Clin Endocrinol Metab. 99:E528–E535. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Fjeldborg K, Christiansen T, Bennetzen M, Møller JH, Pedersen SB and Richelsen B: The macrophage-specific serum marker, soluble CD163, is increased in obesity and reduced after dietary-induced weight loss. Obesity (Silver Spring). 21:2437–2443. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Longenecker CT, Jiang Y, Yun CH, Debanne S, Funderburg NT, Lederman MM, Storer N, Labbato DE, Bezerra HG and McComsey GA: Perivascular fat, inflammation, and cardiovascular risk in HIV-infected patients on antiretroviral therapy. Int J Cardiol. 168:4039–4045. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Knudsen A, Møller HJ, Katzenstein TL, Gerstoft J, Obel N, Kronborg G, Benfield T, Kjaer A and Lebech AM: Soluble CD163 does not predict first-time myocardial infarction in patients infected with human immunodeficiency virus: A nested case-control study. BMC Infect Dis. 13:2302013. View Article : Google Scholar : PubMed/NCBI | |
|
Levy AP, Purushothaman KR, Levy NS, Purushothaman M, Strauss M, Asleh R, Marsh S, Cohen O, Moestrup SK, Moller HJ, et al: Downregulation of the hemoglobin scavenger receptor in individuals with diabetes and the Hp 2–2 genotype: Implications for the response to intraplaque hemorrhage and plaque vulnerability. Circ Res. 101:106–110. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Kowal-Bielecka O, Bielecki M, Guiducci S, Trzcinska-Butkiewicz B, Michalska-Jakubus M, Matucci-Cerinic M, Brzosko M, Krasowska D, Chyczewski L and Kowal K: High serum sCD163/sTWEAK ratio is associated with lower risk of digital ulcers but more severe skin disease in patients with systemic sclerosis. Arthritis Res Ther. 15:R692013. View Article : Google Scholar : PubMed/NCBI | |
|
Shaked I, Hanna DB, Gleißner C, Marsh B, Plants J, Tracy D, Anastos K, Cohen M, Golub ET, Karim R, et al: Macrophage inflammatory markers are associated with subclinical carotid artery disease in women with human immunodeficiency virus or hepatitis C virus infection. Arterioscler Thromb Vasc Biol. 34:1085–1092. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Urbonaviciene G, Martin-Ventura JL, Lindholt JS, Urbonavicius S, Moreno JA, Egido J and Blanco-Colio LM: Impact of soluble TWEAK and CD163/TWEAK ratio on long-term cardiovascular mortality in patients with peripheral arterial disease. Atherosclerosis. 219:892–899. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Moreno JA, Dejouvencel T, Labreuche J, Smadja DM, Dussiot M, Martin-Ventura JL, Egido J, Gaussem P, Emmerich J, Michel JB, et al: Peripheral artery disease is associated with a high CD163/TWEAK plasma ratio. Arterioscler Thromb Vasc Biol. 30:1253–1262. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Moreno JA, Ortega-Gómez A, Delbosc S, Beaufort N, Sorbets E, Louedec L, Esposito-Farèse M, Tubach F, Nicoletti A, Steg PG, et al: In vitro and in vivo evidence for the role of elastase shedding of CD163 in human atherothrombosis. Eur Heart J. 33:252–263. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Nakayama W, Jinnin M, Makino K, Kajihara I, Makino T, Fukushima S, Inoue Y and Ihn H: Serum levels of soluble CD163 in patients with systemic sclerosis. Rheumatol Int. 32:403–407. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Greisen SR, Møller HJ, Stengaard-Pedersen K, Hetland ML, Hørslev-Petersen K, Jørgensen A, Hvid M and Deleuran B: Soluble macrophage-derived CD163 is a marker of disease activity and progression in early rheumatoid arthritis. Clin Exp Rheumatol. 29:689–692. 2011.PubMed/NCBI | |
|
De Rycke L, Baeten D, Foell D, Kruithof E, Veys EM, Roth J and De Keyser F: Differential expression and response to anti-TNFalpha treatment of infiltrating versus resident tissue macrophage subsets in autoimmune arthritis. J Pathol. 206:17–27. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Zizzo G, Guerrieri J, Dittman LM, Merri JT and Cohen PL: Circulating levels of soluble MER in lupus reflect M2c activation of monocytes/macrophages, autoantibody specificities and disease activity. Arthritis Res Ther. 15:R2122013. View Article : Google Scholar : PubMed/NCBI | |
|
Nakayama W, Jinnin M, Makino K, Kajihara I, Makino T, Fukushima S, Sakai K, Inoue Y and Ihn H: CD163 expression is increased in the involved skin and sera of patients with systemic lupus erythematosus. Eur J Dermatol. 22:512–517. 2012.PubMed/NCBI | |
|
Waidmann O, Köberle V, Bettinger D, Trojan J, Zeuzem S, Schultheiß M, Kronenberger B and Piiper A: Diagnostic and prognostic significance of cell death and macrophage activation markers in patients with hepatocellular carcinoma. J Hepatol. 59:769–779. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Lim R, Lappas M, Riley C, Borregaard N, Moller HJ, Ahmed N and Rice GE: Investigation of human cationic antimicrobial protein-18 (hCAP-18), lactoferrin and CD163 as potential biomarkers for ovarian cancer. J Ovarian Res. 6:52013. View Article : Google Scholar : PubMed/NCBI | |
|
No JH, Moon JM, Kim K and Kim YB: Prognostic significance of serum soluble CD163 level in patients with epithelial ovarian cancer. Gynecol Obstet Invest. 75:263–267. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Sugaya M, Miyagaki T, Ohmatsu H, Suga H, Kai H, Kamata M, Fujita H, Asano Y, Tada Y, Kadono T, et al: Association of the numbers of CD163(+) cells in lesional skin and serum levels of soluble CD163 with disease progression of cutaneous T cell lymphoma. J Dermatol Sci. 68:45–51. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Andersen MN, Abildgaard N, Maniecki MB, Møller HJ and Andersen NF: Monocyte/macrophage-derived soluble CD163: A novel biomarker in multiple myeloma. Eur J Haematol. 93:41–47. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Dai C, Yao X, Gordon EM, Barochia A, Cuento RA, Kaler M, Meyer KS, Keeran KJ, Nugent GZ, Jeffries KR, et al: A CCL24-dependent pathway augments eosinophilic airway inflammation in house dust mite-challenged Cd163 mice. Mucosal Immunol. 9:702–717. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Akahori H, Karmali V, Polavarapu R, Lyle AN, Weiss D, Shin E, Husain A, Naqvi N, Van Dam R, Habib A, et al: CD163 interacts with TWEAK to regulate tissue regeneration after ischaemic injury. Nat Commun. 6:77922015. View Article : Google Scholar : PubMed/NCBI | |
|
Etzerodt A, Kjolby M, Nielsen MJ, Maniecki M, Svendsen P and Moestrup SK: Plasma clearance of hemoglobin and haptoglobin in mice and effect of CD163 gene targeting disruption. Antioxid Redox Signal. 18:2254–2263. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Draijer C, Robbe P, Boorsma CE, Hylkema MN and Melgert BN: Characterization of macrophage phenotypes in three murine models of house-dust-mite-induced asthma. Mediators Inflamm. 2013:6320492013. View Article : Google Scholar : PubMed/NCBI | |
|
Liu YC, Zou XB, Chai YF and Yao YM: Macrophage polarization in inflammatory diseases. Int J Biol Sci. 10:520–529. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Byrne AJ, Mathie SA, Gregory LG and Lloyd CM: Pulmonary macrophages: Key players in the innate defence of the airways. Thorax. 70:1189–1196. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Kunz LI, Lapperre TS, Snoeck-Stroband JB, Budulac SE, Timens W, van Wijngaarden S, Schrumpf JA, Rabe KF, Postma DS, Sterk PJ, et al: Smoking status and anti-inflammatory macrophages in bronchoalveolar lavage and induced sputum in COPD. Respir Res. 12:342011. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang X, Zhong W, Meng Q, Lin Q, Fang C, Huang X, Li C, Huang Y and Tan J: Ambient PM2.5 exposure exacerbates severity of allergic asthma in previously sensitized mice. J Asthma. 52:785–794. 2015.PubMed/NCBI | |
|
Martinez-Nunez RT, Louafi F and Sanchez-Elsner T: The interleukin 13 (IL-13) pathway in human macrophages is modulated by microRNA-155 via direct targeting of interleukin 13 receptor alpha1 (IL13Ralpha1). J Biol Chem. 286:1786–1794. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Moreira AP, Cavassani KA, Hullinger R, Rosada RS, Fong DJ, Murray L, Hesson DP and Hogaboam CM: Serum amyloid P attenuates M2 macrophage activation and protects against fungal spore-induced allergic airway disease. J Allergy Clin Immunol. 126:712–721.e7. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Han H, Headley MB, Xu W, Comeau MR, Zhou B and Ziegler SF: Thymic stromal lymphopoietin amplifies the differentiation of alternatively activated macrophages. J Immunol. 190:904–912. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Hamzaoui A, Ammar J and Hamzaoui K: Regulatory T cells in induced sputum of asthmatic children: Association with inflammatory cytokines. Multidiscip Respir Med. 5:22–30. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Siddiqui S, Secor ER Jr and Silbart LK: Broncho-alveolar macrophages express chemokines associated with leukocyte migration in a mouse model of asthma. Cell Immunol. 281:159–169. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Abdullah M, Kahler D, Vock C, Reiling N, Kugler C, Drömann D, Rupp J, Hauber HP, Fehrenbach H, Zabel P, et al: Pulmonary haptoglobin and CD163 are functional immunoregulatory elements in the human lung. Respiration. 83:61–73. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Axelsson J, Møller HJ, Witasp A, Qureshi AR, Carrero JJ, Heimbürger O, Bárány P, Alvestrand A, Lindholm B, Moestrup SK and Stenvinkel P: Changes in fat mass correlate with changes in soluble sCD163, a marker of mature macrophages, in patients with CKD. Am J Kidney Dis. 48:916–925. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Staples KJ, Hinks TS, Ward JA, Gunn V, Smith C and Djukanović R: Phenotypic characterization of lung macrophages in asthmatic patients: Overexpression of CCL17. J Allergy Clin Immunol. 130:1404–1412.e7. 2012. View Article : Google Scholar : PubMed/NCBI |
